tiprankstipranks
Landos Biopharma (LABP)
NASDAQ:LABP
US Market

Landos Biopharma (LABP) Stock Investors

117 Followers
Based on 736,443 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold LABP
On average, investors allocate 0.00% of their portfolios to LABP
The average holding size of this company in investors' portfolios.

Investor Sentiment

Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 736,443 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding LABP

1.3%
Last 7
Days
0.7%
Last 30
Days
Percentages indicate the change in the number of portfolios holding LABP, out of 736,443 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

LABP Investor Activity

No data currently available
Based on the activity of 13,906 investors who made their portfolios public
The table shows changes in LABP in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

LABP Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
DraftKings
5.95%
-0.41%
+0.92%
35.47B
Consumer Cyclical
ChargePoint Holdings
3.97%
-0.90%
-4.00%
753.58M
Consumer Cyclical
Merck & Company
4.10%
-0.13%
-1.21%
327.97B
Healthcare
XPeng, Inc. ADR
5.29%
-0.70%
-4.63%
7.66B
Consumer Cyclical
GE Aerospace
5.46%
-0.34%
-0.84%
183.16B
Industrials
Blink Charging Co
5.22%
-1.04%
-4.80%
322.16M
Industrials
Devon Energy
5.40%
-0.58%
-3.24%
30.43B
Energy
Bristol-Myers Squibb
3.21%
-0.17%
+1.50%
83.60B
Healthcare
Applied Materials
4.84%
+0.77%
+3.72%
182.89B
Technology
Marathon Digital Holdings
5.63%
-0.50%
-2.76%
5.79B
Financial
Based on the activity of 736,443 active portfolios
Open your Smart Portfolio

LABP Investor Analysis

LABP investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
7.4%
of LABP holders
are under 35
Average Segment Performance
Average P/E Ratio22.33
Beta5.97
Dividend Yield9.09%
LABP investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
63.0%
of LABP holders
are between 35–55
Average Segment Performance
Average P/E Ratio21.35
Beta10.72
Dividend Yield6.64%
LABP investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
29.6%
of LABP holders
are over 55
Average Segment Performance
Average P/E Ratio21.12
Beta3.76
Dividend Yield7.19%
Overview of age group and performance of LABP stock investors
See who invests in LABP according to age group and performance.

FAQ

How many retail Investors hold LABP?
<0.1% of TipRanks' retail investors hold LABP in their portfolios.
    What is LABP Investor Sentiment?
    LABP’s Investor Sentiment is Negative.
      What percentage of retail investors changed their holding of LABP in the last 7 days?
      ▼ 1.3% of TipRanks' retail investors changed their holding of LABP in the last 7 days.
        What percentage of retail investors changed their holding of LABP in the last 30 days?
        ▼ 0.7% of TipRanks' retail investors changed their holding of LABP in the last 30 days.
          What is the average age of retail investors who hold LABP?
          The average age of LABP Holders is between 35–55.
            What other stocks have LABP investors also bought?
            LABP Investors also bought DKNG, CHPT, MRK, XPEV, GE, BLNK, DVN, BMY, AMAT, MARA.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ACADACADIA Pharmaceuticals
              ALKSAlkermes
              BDXBecton Dickinson
              BCRXBioCryst
              BSXBoston Scientific
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis